Trial intelligence / Profile preview

Early Vitamin A Supplementation for ROP in Preterm Infants

NCT03154723Completed

Start
Aug 2015
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in retinopathy of prematurity (ROP) comparing Vitamin A Group with Placebo Group (2 arms). Primary endpoint: Rate of Retinopathy of Prematurity at 2 years. Started Aug 2015; status: completed.

02

Drugs

vitamin a
03

Conditions

retinopathy of prematurity (ROP)

Beyond the preview

Go deeper on NCT03154723.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03154723.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call